We are live on ! Find out more
CPA

Capital Performance Advisors Portfolio holdings

AUM $1.5B
1-Year Est. Return 21.4%
This Fund
S&P 500
This Quarter Est. Return
+7.04%
1 Year Est. Return
+21.4%
3 Year Est. Return
+61.53%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$329M
AUM Growth
+$65.6M
Cap. Flow
+$47.9M
Cap. Flow %
14.56%
Top 10 Hldgs %
61.59%
Holding
2,901
New
2,799
Increased
53
Reduced
27
Closed
2

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$772K
2
NVDA icon
NVIDIA
NVDA
+$662K
3
AAPL icon
Apple
AAPL
+$589K
4
MSFT icon
Microsoft
MSFT
+$568K
5
AVGO icon
Broadcom
AVGO
+$431K

Top Sells

Rank Stock Value
1
DFAC icon
Dimensional US Core Equity 2 ETF
DFAC
+$521K
2
DFAT icon
Dimensional US Targeted Value ETF
DFAT
+$503K
3
DCOR icon
Dimensional US Core Equity 1 ETF
DCOR
+$497K
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$488K
5
DFIV icon
Dimensional International Value ETF
DFIV
+$447K

Sector Composition

Rank Sector Weight
1 Technology 10.08%
2 Financials 4.66%
3 Consumer Discretionary 2.92%
4 Healthcare 2.04%
5 Industrials 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ULBI icon
2826
Ultralife
ULBI
$90.1M
$36 ﹤0.01%
+4
New +$41
BALY icon
2827
Bally's
BALY
$686M
$35 ﹤0.01%
+2
New +$32
BBCP icon
2828
Concrete Pumping Holdings
BBCP
$522M
$35 ﹤0.01%
+6
New +$37
IMUX icon
2829
Immunic
IMUX
$188M
$35 ﹤0.01%
+2
New +$28
PGNY icon
2830
Progyny
PGNY
$2.47B
$34 ﹤0.01%
+2
New +$48
FLG
2831
Flagstar Bank National Association
FLG
$5.74B
$34 ﹤0.01%
+3
New +$32
OPFI icon
2832
OppFi
OPFI
$804M
$33 ﹤0.01%
+7
New +$29
IDYA icon
2833
IDEAYA Biosciences
IDYA
$3.54B
$32 ﹤0.01%
+1
New +$38
RIGL icon
2834
Rigel Pharmaceuticals
RIGL
$692M
$32 ﹤0.01%
+2
New +$24
SLP icon
2835
Simulations Plus
SLP
$371M
$32 ﹤0.01%
+1
New +$37
SNAP icon
2836
Snap
SNAP
$7.6B
$32 ﹤0.01%
+3
New +$34
DBI icon
2837
Designer Brands
DBI
$298M
$30 ﹤0.01%
+4
New +$28
HBB icon
2838
Hamilton Beach Brands
HBB
$300M
$30 ﹤0.01%
+1
New +$24
NEO icon
2839
NeoGenomics
NEO
$1.71B
$30 ﹤0.01%
+2
New +$31
LXRX icon
2840
Lexicon Pharmaceuticals
LXRX
$991M
$28 ﹤0.01%
+18
New +$32
LCUT icon
2841
Lifetime Brands
LCUT
$202M
$26 ﹤0.01%
+4
New +$29
AIRS icon
2842
AirSculpt Technologies
AIRS
$331M
$25 ﹤0.01%
+5
New +$22
FENC icon
2843
Fennec Pharmaceuticals
FENC
$355M
$25 ﹤0.01%
+5
New +$29
MFIN icon
2844
Medallion Financial
MFIN
$226M
$24 ﹤0.01%
+3
New +$24
REKR icon
2845
Rekor Systems
REKR
$86M
$24 ﹤0.01%
+20
New +$29
SYM icon
2846
Symbotic
SYM
$5.28B
$24 ﹤0.01%
+1
New +$27
FSLY icon
2847
Fastly Inc
FSLY
$3.14B
$23 ﹤0.01%
+3
New +$21
TNYA icon
2848
Tenaya Therapeutics
TNYA
$167M
$23 ﹤0.01%
+12
New +$34
SFNC icon
2849
Simmons First National
SFNC
$3.32B
$22 ﹤0.01%
+1
New +$20
SKIN icon
2850
SkinHealth Systems
SKIN
$96.9M
$22 ﹤0.01%
+15
New +$25
112 113
114
115 116

Similar funds

SGM
Seven Grand Managers Bronxville, New York $1.5B AUM 57.16% 1-Year Est. Return
MCM
Maple Capital Management Montpelier, Vermont $1.49B AUM 23.46% 1-Year Est. Return
RCW
Rheos Capital Works Tokyo, Japan $1.5B AUM 47.78% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Capital Performance Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Capital Performance Advisors held 2,901 positions worth $329M, up 25% from $263M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Capital Performance Advisors deployed $47.9M of net new capital in Q3 2024, opening 2,799 new positions and adding to 53 existing holdings. Its largest new stake was Broadcom: 2,686 shares worth $463K.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 8.6% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dimensional US Core Equity 2 ETF, an estimated $521K trimmed.

  • Capital Performance Advisors's largest Q3 2024 buy was Broadcom: 2,686 shares worth $463K.
  • Capital Performance Advisors added most to Amazon in Q3 2024, an estimated $772K increase.
  • Capital Performance Advisors's biggest Q3 2024 reduction was Dimensional US Core Equity 2 ETF, cutting an estimated $521K.
  • Capital Performance Advisors fully exited Dimensional US Core Equity 1 ETF in Q3 2024, selling an estimated $497K.
  • Capital Performance Advisors's ten largest holdings make up 62% of its $329M portfolio in Q3 2024.
  • Capital Performance Advisors opened 2,799 new positions and closed 2 in Q3 2024.
  • Capital Performance Advisors's portfolio value rose 25% quarter-over-quarter to $329M.

Based on Capital Performance Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.